Nestle to study diet-disease link with biotech deal: WSJ

Tue Jan 7, 2014 8:00pm EST

Related Topics

(Reuters) - Nestle SA is set to enter a biotechnology partnership with Cellular Dynamics International (CDI) to study the relation between diet and disease, the Wall Street Journal reported.

The maker of Kit Kat chocolate bars and Maggi soups will take brain and liver cells from CDI to study the effect of nutrients found in foods, the Journal cited Emmanuel Baetge, director of the Nestle Institute of Health Sciences, as saying in an interview. (link.reuters.com/buc85v)

Madison, Wisconsin-based CDI develops and manufactures human cells in industrial quantities to precise specifications for customers to research cellular therapeutics, among other uses.

Both companies are expected to announce the deal this week without disclosing the financial terms, the newspaper added.

Nestle and CDI could not be reached for comment outside regular business hours.

(Reporting by Abhirup Roy in Bangalore; Editing by Eric Walsh)

FILED UNDER:
We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
Comments (1)
slowboat42 wrote:
OMG, isn’t this like the fox guarding the chicken coop? We don’t need studies to prove that sugar leads to obesity, then diabetes which leads to by heart disease.

Jim

Jan 07, 2014 8:16pm EST  --  Report as abuse
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.